Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): A retrospective review of 114 patients from the French Sarcoma Group (FSG)

Conservative surgery vs. duodeneopancreatectomy in primary duodenal gastrointestinal stromal tumors (GIST): A retrospective review of 114 patients from the French Sarcoma Group (FSG)
复制标题

DOI:
10.1016/j.ejso.2014.04.011
复制
发表时间:
2014-10-01
期刊:
影响因子:
3.8
通讯作者:
Bonvalot, S.
Bonvalot, S.
中科院分区:
医学2区
文献类型:
--
作者:
Duffaud, F.;Meeus, P.;Bonvalot, S.

文献摘要

被引文献

相似文献

背景:十二指肠胃肠道间质瘤占所有胃肠道间质瘤的3-5%,对患者预后的了解有限。我们对原发性十二指肠胃肠间质瘤进行回顾性分析。方法:通过来自16个FSG中心(n = 105)的调查确定患者,9名患者参加了BFR14试验。数据是从原始数据库和患者档案中收集的,符合法国法律。结果:纳入114例患者,中位年龄为57岁。肿瘤主要起源于D2(33%)或D3(24%),中位大小为5 cm。109例患者切除了原发肿瘤;局部切除(LR, n = 82),胰十二指肠切除术(PD, n = 23), 4例患者资料缺失。切除为RO (n = 87,79%), R1 (n = 8,7%), R2 (n = 6)。肿瘤特征:KIT+ (n = 104), CD34+ (n = 58)。Miettinen风险低(n = 43),高(n = 52)。术前(n = 11)和术后(n = 20)给予伊马替尼。中位随访36个月(2-250个月),98例患者存活,33例复发。5年OS和EFS分别为86.5%和54.5%。LR组和PD组患者的EFS相似(P < 0.05)。在多变量分析中,ECOG、PS和CD34表达是OS的独立预后因素。Miettinen风险和梭形细胞类型是复发的独立预测因素。结论:十二指肠间质瘤切除术患者预后良好。本研究倾向于在没有解剖限制的情况下保留胰腺。与PD相比,LR具有相似的生存率和较小的发病率。(C) 2014 Elsevier Ltd.版权所有。
Background: Duodenal GISTs represent 3-5% of all GISTs with limited understanding of patient outcomes. We conducted a retrospective analysis of primary localized duodenal GISTs.Methods: Patients were identified via a survey from 16 FSG centers (n = 105), and a group of 9 patients enrolled in the BFR14 trial. Data were collected from the original database and patient files, in agreement with French legislation.Results: 114 patients were included, with a median age of 57. Tumors originated mainly in D2 (33%), or D3 (24%), with a median size of 5 cm. 109 patients had resection of the primary tumor; with a Local Resection (LR, n = 82), a pancreaticoduodenectomy (PD, n = 23), and data were missing for 4 patients. Resections were RO (n = 87, 79%), R1 (n = 8, 7%), R2 (n = 6). Tumor characteristics were: KIT+ (n = 104), CD34+ (n = 58). Miettinen risk was low (n = 43), and high (n = 52). Imatinib was administered Preoperatively (n = 11) and post-operatively (n = 20). With a median follow-up of 36 months (2-250), 98 patients are alive, and 33 relapsed. The 5-year OS and EFS rates are 86.5% and 54.5%. EFS was similar for patients in the LR and the PD groups (P > 0.05). In multivariate analysis, ECOG PS, and CD34 expression are independent prognostic factors on OS. Miettinen risk and spindle cell type are independent predictive factors for relapse.Conclusions: Patients with resected duodenal GIST have a reasonably favorable prognosis. This study favors a preservation of pancreas when there are no anatomical constraints. LR exhibit similar survival and smaller morbidity then PD. (C) 2014 Elsevier Ltd. All rights reserved.